WU, FENG XIA – Trademark Portfolio

Entity Type: 01

WU, FENG XIA holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include REVIX. The owner is based in CHAOYANG DISTRICT, BEIJING.

NO. 401, UNIT 3, BUILDING 10, DONGLI

SECOND DISTRICT, CHAOXIN JIAYUAN

CHAOYANG DISTRICT, BEIJING 100020 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REVIX
REVIX
Registered 2020
REVIX
REVIX
Registered 2019

Trademark Classifications

WU, FENG XIA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does WU, FENG XIA have?

WU, FENG XIA has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does WU, FENG XIA file in?

WU, FENG XIA files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are WU, FENG XIA's most well-known trademarks?

WU, FENG XIA's registered trademark portfolio includes well-known marks such as REVIX. These are among 2 currently registered trademarks in the portfolio.

What is WU, FENG XIA's trademark registration success rate?

WU, FENG XIA has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.